Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2009-08-17 M&A Activity
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
M&A Activity 2009
M&A Activity Classification · 99% confidence The document is a formal statement ('Redegørelse') issued by the Board of Directors ('Bestyrelsen') of Gudme Raaschou Vision A/S regarding a mandatory purchase offer ('pligtmæssigt købstilbud') made by another entity, in accordance with Danish securities law (§ 14 in bekendtgørelse nr. 947). This document outlines the board's position on the takeover bid, referencing the offer document and advising shareholders. This content strongly aligns with the description of a document related to a takeover or merger proposal, which corresponds to the 'M&A Activity' category (TAR). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it addresses a specific M&A event.
2009-08-17 English
M&A Activity 2009
M&A Activity Classification · 98% confidence The document is titled 'TILBUDS ANNONCERING' (Tender Announcement) and explicitly states that KlimaInvest A/S is making a voluntary takeover bid (frivilligt overtagelsestilbud) to the shareholders of Gudme Raaschou Vision A/S. It details the offer price (DKK 25.00 per share) and the offer period (August 6, 2009, to September 4, 2009). This content directly relates to a merger or takeover proposal. Therefore, the appropriate classification is M&A Activity (TAR).
2009-08-10 English
M&A Activity 2009
M&A Activity
2009-08-10 Danish
M&A Activity 2009
M&A Activity
2009-07-27 Danish
Proxy Solicitation & Information Statement 2009
Proxy Solicitation & Information Statement Classification · 99% confidence The document is a formal offer made by 'Pantebrevsselskabet af 2. juni 2009 A/S' to acquire all outstanding shares of 'Gudme Raaschou Vision A/S'. It explicitly states it is a 'pligtmæssigt købstilbud' (mandatory takeover bid) prepared in accordance with Danish securities trading law ('værdipapirhandelsloven') and regulations concerning takeover bids ('overtagelsestilbud'). This document details the offer price, terms, background, and future intentions regarding the target company, which is characteristic of a Tender Offer document. The closest matching category among the provided definitions is 'M&A Activity' (Code: TAR), as a takeover bid is a form of M&A transaction. It is not a general regulatory filing (RNS) because it is a highly specific document type (Tender Offer Document).
2009-07-27 English
Major Shareholding Notification 2009
Major Shareholding Notification
2009-07-01 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.